Loading clinical trials...
Loading clinical trials...
Researchers are looking for new ways to treat people with high-risk non-muscle invasive bladder cancer (HR NMIBC). NMIBC is cancer in the tissue that lines the inside of the bladder but has not spread...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Merck Sharp & Dohme LLC
Collaborators
NCT05614739 · Urinary Bladder Neoplasms, Neoplasm Metastasis, and more
NCT06184750 · Breast Atypical Ductal Hyperplasia, Breast Atypical Lobular Hyperplasia, and more
NCT06319820 · Non-Muscle Invasive Bladder Neoplasms
NCT06919965 · Non-Muscle Invasive Bladder Neoplasms
NCT06075953 · Ductal Carcinoma in Situ
Michael G Oefelein Clinical Trials ( Site 0138)
Bakersfield, California
Genesis Research, LLC ( Site 0141)
Los Alamitos, California
USC Norris Comprehensive Cancer Center ( Site 0123)
Los Angeles, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions